Edgewell Personal Care | 8-K: FY2025 Q3 Revenue Misses Estimate at USD 627.2 M

LB filings
2025.08.05 10:13
portai
I'm PortAI, I can summarize articles.

Revenue: As of FY2025 Q3, the actual value is USD 627.2 M, missing the estimate of USD 653.63 M.

EPS: As of FY2025 Q3, the actual value is USD 0.62.

EBIT: As of FY2025 Q3, the actual value is USD 37.2 M.

Segment Revenue

  • Wet Shave: Net sales increased by $0.7 million, or 0.2%, with organic net sales decreasing by $5.7 million, or 1.8%.
  • Sun and Skin Care: Net sales decreased by $13.5 million, or 5.3%, with organic net sales decreasing by $14.1 million, or 5.5%.
  • Feminine Care: Net sales decreased by $7.8 million, or 10.5%, with minimal currency impact.

Operational Metrics

  • Net Income: GAAP net earnings were $29.1 million, or $0.62 per diluted share, compared to $49.0 million, or $0.98 per diluted share in the prior year quarter.
  • Gross Margin: Gross profit was $268.5 million, compared to $287.1 million in the prior year quarter. Adjusted gross margin decreased by 150 basis points to 42.8%.
  • Operating Profit: Operating income was $53.7 million, or 8.6% of net sales, compared to $82.7 million, or 12.8% of net sales in the prior year quarter.
  • Operating Margin: Adjusted operating income was $75.1 million, or 12.0% of net sales, compared to $94.8 million, or 14.6% of net sales in the prior year quarter.
  • Operating Costs: SG&A expenses were $104.4 million, or 16.6% of net sales, compared to $110.1 million, or 17.0% of net sales in the prior year quarter.

Cash Flow

  • Operating Cash Flow: Net cash provided by operating activities was $44.3 million for the nine months ending June 30, 2025, compared to $157.3 million in the prior year period.
  • Free Cash Flow: Free cash flow is expected to be approximately $80 million for fiscal 2025.

Unique Metrics

  • Adjusted EBITDA: Adjusted EBITDA was $96.4 million, inclusive of a $7.8 million unfavorable currency impact, compared to $117.2 million in the prior year quarter.

Outlook / Guidance

  • Fiscal Year 2025 Outlook: The company expects organic net sales to decrease approximately 1.3%, with GAAP EPS expected to be approximately $1.73 and adjusted EPS approximately $2.65.
  • Currency Impact: Currency is now expected to positively impact reported net sales by 10 basis points.
  • Adjusted EBITDA: Expected to be approximately $312 million, including an estimated $29 million unfavorable impact from foreign currency changes.